Praveen Tyle is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving on the Board of Directors for multiple companies including iXCells Biotechnologies, Gila Therapeutics, and Remunity Therapeutics, Praveen plays a pivotal role in advancing pre-clinical drug discovery, novel treatments for metabolic disorders, and immuno-oncology. As the founder of Potens Pharmaceuticals, Praveen specializes in "Speed to Market" strategies for healthcare products. Additional board positions include leadership roles at Kiora Pharmaceuticals and OEP Group, focusing on ophthalmic therapies and health product commercialization, respectively. Praveen’s educational background includes a PhD in Pharmaceutics and Pharm Chemistry from The Ohio State University and a B. Pharmacy (Honors) from the Indian Institute of Technology (Banaras Hindu University).
This person is not in the org chart
This person is not in any teams